Use of Radiation Therapy in Locally Advanced Pancreatic Cancer Improves Survival

Monique Sajjad, Sachin Batra, Sarah Hoffe, Richard Kim, Gregory Springett, Amit Mahipal

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Objectives: Although both radiation therapy and chemotherapy are frequently used to treat locally advanced pancreatic cancer (LAPC) patients, the role of radiation therapy remains controversial with data evaluating its efficacy mostly derived from small randomized trials. In this study, we evaluate the survival benefit of radiation therapy using SEER dataset in patients with LAPC. Materials and Methods: The SEER Registry dataset from 2004 to 2011 was queried to identify LAPC (TNM stage III) patients. Patients with survival <2 months, unknown radiation status, or who received postoperative radiation were excluded. Multivariate analyses of prognostic factors related to survival were performed using a Cox proportional hazard-regression model. Propensity scores were estimated using probit regression. Results: Our search identified 4460 patients; 59% who received radiation and 41% who did not. Radiation group patients were younger (below 65 y old: 49% vs. 38%), had smaller tumor size (largest dimension <4.5 cm: 80% vs. 75%), less lymph node involvement (33% vs. 36%), and lower rate of surgical resection (4% vs. 9%). Patients who received radiation therapy had better survival (HR=0.773; 95% CI, 0.687-0.782). The 12-month overall survival in the radiation group and nonradiation group was 43% versus 29%, respectively (P<0.001). On multivariate analyses, radiation was independently associated with improved outcomes. The survival benefit with radiation was observed in propensity score-matched cohort. Conclusions: Radiation therapy was associated with improved survival. Prospective randomized trials are needed to confirm these findings. The optimal schedule and radiation type remain undetermined.

Original languageEnglish (US)
Pages (from-to)236-241
Number of pages6
JournalAmerican Journal of Clinical Oncology: Cancer Clinical Trials
Volume41
Issue number3
DOIs
StatePublished - Jan 1 2018
Externally publishedYes

Fingerprint

Pancreatic Neoplasms
Radiotherapy
Radiation
Survival
Propensity Score
Multivariate Analysis
Proportional Hazards Models
Registries
Appointments and Schedules
Lymph Nodes
Drug Therapy
Neoplasms

Keywords

  • pancreatic cancer
  • propensity score
  • radiotherapy
  • retrospective study
  • SEER database

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Use of Radiation Therapy in Locally Advanced Pancreatic Cancer Improves Survival. / Sajjad, Monique; Batra, Sachin; Hoffe, Sarah; Kim, Richard; Springett, Gregory; Mahipal, Amit.

In: American Journal of Clinical Oncology: Cancer Clinical Trials, Vol. 41, No. 3, 01.01.2018, p. 236-241.

Research output: Contribution to journalArticle

Sajjad, Monique ; Batra, Sachin ; Hoffe, Sarah ; Kim, Richard ; Springett, Gregory ; Mahipal, Amit. / Use of Radiation Therapy in Locally Advanced Pancreatic Cancer Improves Survival. In: American Journal of Clinical Oncology: Cancer Clinical Trials. 2018 ; Vol. 41, No. 3. pp. 236-241.
@article{22c84bf2c191411ebf6a5bb61b4d1ce2,
title = "Use of Radiation Therapy in Locally Advanced Pancreatic Cancer Improves Survival",
abstract = "Objectives: Although both radiation therapy and chemotherapy are frequently used to treat locally advanced pancreatic cancer (LAPC) patients, the role of radiation therapy remains controversial with data evaluating its efficacy mostly derived from small randomized trials. In this study, we evaluate the survival benefit of radiation therapy using SEER dataset in patients with LAPC. Materials and Methods: The SEER Registry dataset from 2004 to 2011 was queried to identify LAPC (TNM stage III) patients. Patients with survival <2 months, unknown radiation status, or who received postoperative radiation were excluded. Multivariate analyses of prognostic factors related to survival were performed using a Cox proportional hazard-regression model. Propensity scores were estimated using probit regression. Results: Our search identified 4460 patients; 59{\%} who received radiation and 41{\%} who did not. Radiation group patients were younger (below 65 y old: 49{\%} vs. 38{\%}), had smaller tumor size (largest dimension <4.5 cm: 80{\%} vs. 75{\%}), less lymph node involvement (33{\%} vs. 36{\%}), and lower rate of surgical resection (4{\%} vs. 9{\%}). Patients who received radiation therapy had better survival (HR=0.773; 95{\%} CI, 0.687-0.782). The 12-month overall survival in the radiation group and nonradiation group was 43{\%} versus 29{\%}, respectively (P<0.001). On multivariate analyses, radiation was independently associated with improved outcomes. The survival benefit with radiation was observed in propensity score-matched cohort. Conclusions: Radiation therapy was associated with improved survival. Prospective randomized trials are needed to confirm these findings. The optimal schedule and radiation type remain undetermined.",
keywords = "pancreatic cancer, propensity score, radiotherapy, retrospective study, SEER database",
author = "Monique Sajjad and Sachin Batra and Sarah Hoffe and Richard Kim and Gregory Springett and Amit Mahipal",
year = "2018",
month = "1",
day = "1",
doi = "10.1097/COC.0000000000000261",
language = "English (US)",
volume = "41",
pages = "236--241",
journal = "American Journal of Clinical Oncology: Cancer Clinical Trials",
issn = "0277-3732",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Use of Radiation Therapy in Locally Advanced Pancreatic Cancer Improves Survival

AU - Sajjad, Monique

AU - Batra, Sachin

AU - Hoffe, Sarah

AU - Kim, Richard

AU - Springett, Gregory

AU - Mahipal, Amit

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Objectives: Although both radiation therapy and chemotherapy are frequently used to treat locally advanced pancreatic cancer (LAPC) patients, the role of radiation therapy remains controversial with data evaluating its efficacy mostly derived from small randomized trials. In this study, we evaluate the survival benefit of radiation therapy using SEER dataset in patients with LAPC. Materials and Methods: The SEER Registry dataset from 2004 to 2011 was queried to identify LAPC (TNM stage III) patients. Patients with survival <2 months, unknown radiation status, or who received postoperative radiation were excluded. Multivariate analyses of prognostic factors related to survival were performed using a Cox proportional hazard-regression model. Propensity scores were estimated using probit regression. Results: Our search identified 4460 patients; 59% who received radiation and 41% who did not. Radiation group patients were younger (below 65 y old: 49% vs. 38%), had smaller tumor size (largest dimension <4.5 cm: 80% vs. 75%), less lymph node involvement (33% vs. 36%), and lower rate of surgical resection (4% vs. 9%). Patients who received radiation therapy had better survival (HR=0.773; 95% CI, 0.687-0.782). The 12-month overall survival in the radiation group and nonradiation group was 43% versus 29%, respectively (P<0.001). On multivariate analyses, radiation was independently associated with improved outcomes. The survival benefit with radiation was observed in propensity score-matched cohort. Conclusions: Radiation therapy was associated with improved survival. Prospective randomized trials are needed to confirm these findings. The optimal schedule and radiation type remain undetermined.

AB - Objectives: Although both radiation therapy and chemotherapy are frequently used to treat locally advanced pancreatic cancer (LAPC) patients, the role of radiation therapy remains controversial with data evaluating its efficacy mostly derived from small randomized trials. In this study, we evaluate the survival benefit of radiation therapy using SEER dataset in patients with LAPC. Materials and Methods: The SEER Registry dataset from 2004 to 2011 was queried to identify LAPC (TNM stage III) patients. Patients with survival <2 months, unknown radiation status, or who received postoperative radiation were excluded. Multivariate analyses of prognostic factors related to survival were performed using a Cox proportional hazard-regression model. Propensity scores were estimated using probit regression. Results: Our search identified 4460 patients; 59% who received radiation and 41% who did not. Radiation group patients were younger (below 65 y old: 49% vs. 38%), had smaller tumor size (largest dimension <4.5 cm: 80% vs. 75%), less lymph node involvement (33% vs. 36%), and lower rate of surgical resection (4% vs. 9%). Patients who received radiation therapy had better survival (HR=0.773; 95% CI, 0.687-0.782). The 12-month overall survival in the radiation group and nonradiation group was 43% versus 29%, respectively (P<0.001). On multivariate analyses, radiation was independently associated with improved outcomes. The survival benefit with radiation was observed in propensity score-matched cohort. Conclusions: Radiation therapy was associated with improved survival. Prospective randomized trials are needed to confirm these findings. The optimal schedule and radiation type remain undetermined.

KW - pancreatic cancer

KW - propensity score

KW - radiotherapy

KW - retrospective study

KW - SEER database

UR - http://www.scopus.com/inward/record.url?scp=84954568320&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84954568320&partnerID=8YFLogxK

U2 - 10.1097/COC.0000000000000261

DO - 10.1097/COC.0000000000000261

M3 - Article

C2 - 26796313

AN - SCOPUS:84954568320

VL - 41

SP - 236

EP - 241

JO - American Journal of Clinical Oncology: Cancer Clinical Trials

JF - American Journal of Clinical Oncology: Cancer Clinical Trials

SN - 0277-3732

IS - 3

ER -